Hemodynamic effects of benazepril, an angiotensin-converting enzyme inhibitor, as studied in conscious normotensive dogs.

Author: ImaiS, IshibashiT, MitomiA, TanakaM, TatebeS

Paper Details 
Original Abstract of the Article :
Hemodynamic effects and inhibitory effects on the pressor response to exogenous angiotensin I of benazepril (CGS 14824A), a new angiotensin-converting enzyme (ACE) inhibitor, were examined in conscious chronically instrumented normotensive dogs in comparison with those of captorpil. Oral administrat...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/BF03029732

データ提供:米国国立医学図書館(NLM)

Benazepril: A New Angiotensin-Converting Enzyme (ACE) Inhibitor

Imagine a camel caravan navigating a treacherous desert landscape, where every step requires careful consideration. This study explores the hemodynamic effects of benazepril, a new ACE inhibitor, in conscious normotensive dogs. It's like studying the intricate workings of a camel's circulatory system, uncovering the effects of this drug on blood pressure.

This research investigates the hemodynamic effects of benazepril in comparison to captopril. The authors find that benazepril is a potent ACE inhibitor with a slower onset and longer duration of action than captopril. It's like observing two camels, one with a quick, energetic gait and the other with a steady, measured pace. This study highlights the importance of understanding the specific characteristics of different drugs within a class.

A Different Pace: Exploring the Effects of Benazepril

This study provides valuable insights into the potential benefits and challenges of using benazepril. It highlights the importance of careful monitoring and individualized therapy for patients taking this medication. It's like understanding the unique requirements of each camel in a caravan, tailoring their care to ensure a successful journey through the desert.

Navigating the Cardiovascular Desert: A New Path

This research offers a glimpse into the evolving landscape of cardiovascular treatments. By exploring new drugs like benazepril, we can continue to advance our understanding and treatment options for cardiovascular disease. It's like discovering a new route through the desert, offering new possibilities for a healthier journey.

Dr. Camel's Conclusion

This study sheds light on the potential benefits and challenges of using benazepril as an ACE inhibitor. It's a reminder that even within a single class of drugs, there can be significant variation in effects, making individualized care crucial for optimal outcomes.

Date :
  1. Date Completed 1991-09-30
  2. Date Revised 2019-09-12
Further Info :

Pubmed ID

1652276

DOI: Digital Object Identifier

10.1007/BF03029732

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.